3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Head and Neck Neoplasms
3
Esophageal Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Neoplasms
2
Lung Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Thoracic Diseases
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Sarcoma
1
Prolactinoma
1
Pituitary ACTH Hypersecretion
1
Peritoneal Diseases
1
Paraproteinemias
1
Ovarian Neoplasms
1
Ovarian Diseases
1
Nervous System Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Monoclonal Gammopathy of Undetermined Significance
1
Mesothelioma, Malignant
1
Lymphoma
1
Liver Neoplasms
1
Leukemia
1
Leiomyosarcoma
1
Immunoglobulin Light-chain Amyloidosis
1
Gigantism
1
Interventions
Gene Expression Profiling
9
Surveys and Questionnaires
7
Blood Specimen Collection
7
Surgical Procedures, Operative
6
Polymerase Chain Reaction
6
Microarray Analysis
4
Immunohistochemistry
4
Base Sequence
4
Trabectedin
3
Therapeutics
3
Reverse Transcriptase Polymerase Chain Reaction
3
Radiation
3
Psychiatric Rehabilitation
3
Observation
3
Drug Therapy
3
Radiotherapy
2
Patient Reported Outcome Measures
2
Molecular Diagnostic Techniques
2
Methods
2
In Situ Hybridization, Fluorescence
2
Gene Rearrangement
2
DNA Methylation
2
Amplified Fragment Length Polymorphism Analysis
2
trastuzumab deruxtecan
1
pazopanib
1
liposomal doxorubicin
1
fluorodopa F 18
1
eribulin
1
Watchful Waiting
1
Urine Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Sarcoma
×
Tissue Banks
×
Clear all
NCT06482957
2025-09-19
CAUSAL
Vanderbilt-Ingram Cancer Center
Recruiting
2,100 enrolled